Literature DB >> 31331584

How do people with refractory irritable bowel syndrome perceive hypnotherapy?: Qualitative study.

Matthew Krouwel1, Kate Jolly2, Sheila Greenfield2.   

Abstract

OBJECTIVES: Hypnotherapy is recognised in the UK's National Institute for Health and Care Excellence (NICE) guidelines as a potential treatment for Irritable Bowel Syndrome (IBS). However, little is known about the views of people with IBS regarding hypnotherapy. This qualitative study aimed to identify perceptions of and barriers to hypnotherapy for IBS by people with the condition.
DESIGN: One-to-one semi-structured interviews using thematic analysis.
SETTING: Convenience sampling in the UK. Participants were recruited by poster advertising and online IBS support groups. Interviews were conducted at the interviewees' preferred location or via video calling. PARTICIPANTS: 17 people (15 female, 2 male) who self-identified as having refractory IBS according to a provided definition.
RESULTS: Four hypnotherapy related themes arose from the data: conceptualisation of hypnotherapy, hypnotherapy for IBS, barriers to hypnotherapy for IBS, ideal format of hypnotherapy for IBS. Participants saw hypnosis as an altered state in which change was possible, but many had not considered it for IBS. They were broadly open to hypnotherapy for IBS, but a variety of potential barriers were apparent, including cost and therapist validity. Group hypnotherapy was less acceptable than one-to-one treatment. Hypnotherapy via video call was seen as convenient, but there were concerns about its effectiveness.
CONCLUSION: People with IBS may be put off hypnotherapy by a lack of understanding of how it works for their condition and lack of awareness of it as a therapeutic option. Uptake may be improved through effective promotion of the approach which addresses its mechanisms of effect.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Hypnosis; Hypnotherapy; IBS; Irritable bowel syndrome; Qualitative

Year:  2019        PMID: 31331584     DOI: 10.1016/j.ctim.2019.05.020

Source DB:  PubMed          Journal:  Complement Ther Med        ISSN: 0965-2299            Impact factor:   2.446


  4 in total

1.  Pharmacologic, Dietary, and Psychological Treatments for Irritable Bowel Syndrome With Constipation: Cost Utility Analysis.

Authors:  Eric D Shah; Jessica K Salwen-Deremer; Peter R Gibson; Jane G Muir; Shanti Eswaran; William D Chey
Journal:  MDM Policy Pract       Date:  2021-01-18

2.  Hypnotherapy for irritable bowel syndrome: patient expectations and perceptions.

Authors:  Anne-Sophie Donnet; Syed Shariq Hasan; Peter J Whorwell
Journal:  Therap Adv Gastroenterol       Date:  2022-02-15       Impact factor: 4.409

3.  Challenges and opportunities for use of long-lasting insecticidal nets to prevent malaria during overnight travel in Uganda: a qualitative study.

Authors:  Deborah Ekusai-Sebatta; Emmanuel Arinaitwe; Arthur Mpimbaza; Joaniter I Nankabirwa; Chris Drakeley; Philip J Rosenthal; Sarah G Staedke; Herbert Muyinda
Journal:  Malar J       Date:  2021-06-26       Impact factor: 2.979

4.  Comparing Skype (video calling) and in-person qualitative interview modes in a study of people with irritable bowel syndrome - an exploratory comparative analysis.

Authors:  Matthew Krouwel; Kate Jolly; Sheila Greenfield
Journal:  BMC Med Res Methodol       Date:  2019-11-29       Impact factor: 4.615

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.